Product Code: LUNG(NSCLC)[Tissue]-25
From £285.00
Registration closed: 28/02/2025
Applicable to all labs undertaking molecular testing for this cancer type using FFPE tissue.
It is MANDATORY to participate in this EQA scheme for the COMMON BIOMARKERS option, you must also select an item from the Lung New and Emerging biomarkers options. if you do not want to participate select “I do not wish to purchase Lung New and Emerging”
Any molecular test
English, Italian, Spanish
FFPE (real human tumour tissue and artificial materials)
Yes
The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.
Mock clinical cases with matching real human tumour tissue paraffin embedded (FFPE) and artificial FFPE reference materials (designed to simulate real patient samples) are provided for both the COMMON BIOMARKERS and the NEW & EMERGING BIOMARKERS. Five cases are provided for each EQA option. One 10um or 15um thick FFPE section per case is provided.
Variant allele frequencies of the artificial FFPE materials have been validated using ddPCR.
Participants will receive an individual report including educational advice and a scheme summary report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics which allow participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
Open to laboratories from ALL countries (note: some restrictions may apply*)
*Sanctions, delivery network exceptions, restrictions on importation etc.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.